Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.



Education

Pharmaceutical

Design Therapeutics

Sean Jeffries

James Gomez

Julie Burgess

Nancy Levin

Aaron Young

Jim Kerr

Laura Weston

Niamh O'Brien

Mustapha Parekh

The executive team at Design Therapeutics has a wide range of experience in different industries. They have worked as a principal at Marlinspike Group, a project leader at The Boston Consulting Group, and the head of biological sciences at Templeman Automation. They also have a strong educational background, with degrees from the College of Wooster and the University of Cambridge.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Design Therapeutics

Board of Directors

Leadership Team